Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 0 | 0 | 0 | 12 | 75 |
| Gross Profit | N/A | N/A | N/A | 12 | 75 |
| Operating Expenses | 2,417 | 1,561 | 2,022 | 1,073 | 671 |
| Operating Income | -2,417 | -1,561 | -2,022 | -1,060 | -596 |
| Interest Expense | 247 | 152 | 253 | 269 | 229 |
| Other Income | -17 | -8 | 12 | 80 | 97 |
| Pre-tax Income | -2,681 | -1,721 | -2,264 | -1,250 | -728 |
| Net Income Continuous | -2,681 | -1,721 | -2,264 | -1,250 | -728 |
| Net Income | $-2,681 | $-1,721 | $-2,264 | $-1,250 | $-728 |
| EPS Basic Total Ops | -17.60 | -22.84 | -16.90 | -10.76 | 0.00 |
| EPS Basic Continuous Ops | -17.57 | -12.91 | -16.91 | -10.75 | -9.84 |
| EPS Diluted Total Ops | -17.60 | -22.84 | -16.90 | -10.76 | 0.00 |
| EPS Diluted Continuous Ops | -17.57 | -12.91 | -16.91 | -10.75 | -9.84 |
| EBITDA(a) | $-2,295 | $-1,437 | $-1,797 | $-818 | $-391 |